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Purpose: This study was designed to compare the effect on postoperative pain, opioid consumption and the length of 
stay in postoperative care unit (PACU) after three different intraoperative analgesic regimens in thyroid surgery. 
Methods: Seventy five patients were enrolled into the study and assigned to one of three groups, fentanyl, sufentanil or 
remifentanil (n=25 for each group). Before the end of surgery, paracetamol 1 gr and nefopam 20 mg was also 
administered in all patients. Pain scores, opioid demand and the length of stay in PACU were assessed in a blind 
manner.  Results: Post operative pain scores were significantly lower in the fentanyl and sufentanil groups compared to 
remifentanil group (55 ± 15, and 60 ± 10 versus 78± 12, P < 0.05). Patients in the remifentanil group stayed longer in the 
PACU 108± 37 min versus 78±31 and 73 ± 25 min, (P< 0.05).  Conclusion: After remifentanil based analgesia, anticipation 
of postoperative pain with opioid analgesic appears mandatory even for surgery rated as being moderately painful, 
otherwise longer opioid titration due to higher pain scores might delay discharge time.       
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1.  INTRODUCTION 
Post operative pain after thyroid surgery might be 
important especially in the early postoperative hours. 
Different techniques or medications including non-
steroidal anti-inflammatory drugs (NSAID) in combination 
with propacetamol, oral morphine, buprenorphine, local 
anesthetics using either infiltration or combined superficial 
and deep cervical blockade have been assessed and/or 
suggested [1-4]. We hypothesized that the choice of opioid 
analgesic regimen might influence the immediate 
postoperative period especially the pain scores and the 
length of stay in the post anesthetic care unit (PACU).  In 
this open randomized study, we compared postoperative 
pain management using three different intraoperative 
opioid analgesic regimens.  
2.  METHODS 
After the approval of institutional review board of 
hospital Henri-Mondor and the informed consent obtained 
from each patient, seventy five adults ASA I-II scheduled 
for elective total thyroidectomy for multinodular goiter 
were enrolled into the study. All patients were euthyroid 
before surgery which was performed by the same surgeon. 
Patients were excluded if they had any analgesic 
medication or corticosteroid drug prior surgery. They were 
instructed the day before surgery about the study design 
and to express their pain in a 101 mm Visual Analogic 
Scale, [0 = no pain, 100 = maximum pain] (VAS). 
Premedication was hydroxyzine 50 mg 1 hour before 
surgery.  
Patients were assigned according to a computerized 
list of random numbers into 3 groups. Group Fentanyl 
(n=25), group Sufentanil (n=25) and group Remifentanil 
(n=25). All patients had general anesthesia induced with 
propofol, 2.5-4 mg/kg.  Tracheal intubation was performed 
without muscle relaxant, and anesthesia was maintained 
with isoflurane (end tidal 0.7-1%) and N2O/O2(50/50). 
Analgesia was started with a bolus fentanyl 2-3 µg/kg, 
sufentanil 0.2-0.3 µg/kg, or remifentanil 0.4-5 µg/kg and 
maintained with boluses of fentanyl 0.5-1µg/kg, sufentanil 
0.08-0.15 µg/kg, until the end of the dissection of the first 
thyroid lobe while the infusion of remifentanil 0.05-0.25 
µg/kg/min was maintained until the last surgical stitch.  
If surgery had to be prolonged because of cancer or 
other surgical complication, the patient was excluded from 
the study and additional patients were enrolled. 
After the dissection of the first thyroid lobe, all 
patients received 1g of paracetamol and 20 mg nefopam IV 
as part of multimodal prevention of postoperative pain. 
Except for the remifentanil group, no other analgesic was 
injected until extubation. Patients were extubated in the 
operating room.  
In the operating room 
The following parameters were recorded: Duration of 
anesthesia, duration of surgery, intraoperative anesthetics 
requirements and time to extubation defined as the delay 
between the end of surgery and extubation.   
In the PACU  
Clinical monitoring consisted of continuous EKG, 
pulse oximetry non invasive intermittent blood pressure 
measurements, respiratory frequency, pulse oximetry and 
temperature measurement with an infrared tympanic 
thermometer. The PACU staff and nurses were not aware 
of the analgesic assignment. 
The following regimen of morphine  titration was 
established in the PACU. Upon extubation patients were 
asked to rate pain in a (0-100mm) VAS, when the VAS 
score was greater than 40 mm  intravenous morphine was 
titrated every 5 min in 2 mg increments and pain was 
assessed every 5 min until relief (VAS< 40). The following 
parameters were recorded: time of extubation, first VAS 
pain scores, the necessity, the amount of morphine titration 
to reach a VAS of < 40, the incidence of nausea and Int. J. Med. Sci. 2006, 3 
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vomiting and sedation score (0=awake, 1=mild, 2=sleepy 
but awakable, and 3 = very sleepy) and the length of stay 
in the PACU. The latter was decided by a physician 
unaware of the randomisation and based by stable vital 
signs for at least 30 min, VAS pain score of less than 40, 
lack of surgical complication, absence of opioid related side 
effects (nausea and vomiting) and a core temperature 
above 36° C.  
In the surgical ward 
Paracetamol injections were repeated systematically 
every 6 hours, while nefopam was repeated every 8 hours 
with a pain score evaluation by a nurse every 4 hours. If 
the VAS score was higher than 40, subcutaneous morphine 
5-10 mg was injected.  
Maximum postoperative pain scores, the necessity of 
morphine injection, the incidence of opioid related side 
effects (nausea and vomiting, and sedation) were noted for 
the first 24 postoperative hours.  
Statistical analysis 
The sample size was calculated to obtain a difference 
in the immediate postoperative pain scores of 30 mm and a 
standard deviation of 15, with a power of 0.8, a P value of 
0.05 was considered to be significant. Data were analyzed 
using Jandel Sigmastat statistical software (San Rafael, Ca, 
USA). ANOVA and Kruskall Wallis Rank sum test were 
used for comparison between groups depending on 
distribution.  
3.  RESULTS 
Six patients were withdrawn from the study: 4 out of 
6 for prolonged surgery for the presence of cancer, and 2 
out of 6 for surgical hematoma and drainage. All other 
patients completed the study. Demographic characteristics 
and intraoperative anesthetics requirements are 
represented in Table 1 and 2. 
Table 1. Patients characteristics 
 Group 
Sufentanil 
(n=24) 
Group 
Fentanyl 
(n=24) 
Group 
Remifentanil 
(n=21) 
Weight (kg)  70±16 68±18 71±18 
Height (cm)  168±7 170±9 168±8 
Age (yr)  44±12 48±14 47±13 
(male /female)  9/15 7/17  7/14 
Values are ± SD as appropriate.  
 
Extubation delays were significantly lower in the 
remifentanil group, P<0.05, (Table 2). 
The initial postoperative pain scores in the PACU 
were significantly lower in the sufentanil and fentanyl 
group compared to remifentanil group, (P<0.05). The 
necessity and total amount of morphine titration in the 
PACU were significantly less in the sufentanil and fentanyl 
group compared to the remifentanil group, (P<0.05) Table 
2.  
In the surgical ward, maximum pain scores and the 
incidence and the amount of morphine requirements were 
not different between groups. 
No patient had heavy sedation in either of the groups.  
The incidence of nausea and vomiting was not 
different between groups.  
Table 2. Intraoperative anesthetic and surgical characteristics, 
Pain scores, length of stay in the PACU, opioid demand and 
opioid related side effects. 
   Group 
Sufentanil  
(n=24) 
Group 
Fentanyl 
(n=24) 
Group 
Remifentanil 
(n=21) 
significance 
Sufentanil/Fentanyl/
Remifentanil (µg) 
25±5/-/- -
/260±65/- 
-/-/650±260  NA 
Duration of surgery 
(min) 
70± 22  80± 23  73±25 NS 
Extubation delay 
(min) 
10 ± 6   12 ± 5  4±3*   P<0.05 
VAS (mm) After 
extubation 
55±15 60  ±10 78±12* P<0.05 
 
 Necessity of Titration 
 
11/24 
 
13/24 
 
21/21* 
 
P<0.05 
Amount of morphine 
in PACU (mg) 
4±3 5±3 10±4* P<0.05 
Length of stay in the 
PACU (min) 
78±31 73±25 108±30* P<0.05 
Incidence of PONV 
(%) 
46% 43%  52%  NS 
Sedation ; (0/1/2/3)  12/12/0/0  10/14/0/
0 
12/9/0/0 NS 
Maximum 
postoperative pain 
scores in the ward  
(First 24 hours) 
50±20 55±23 50±25 NS 
Additional morphine 
in the surgical ward 
(First 24 hours) 
12% 13%  15%  NS 
* Group remifentanil versus group fentanyl and sufentanil. (PACU = post 
anesthetic care unit, PONV = postoperative nausea and vomiting, VAS = visual 
analgesic scale) 
4.  DISCUSSION 
This study shows that the combination of paracetamol 
and nefopam alone was not sufficient to adequately control 
postoperative pain after thyroid surgery especially after 
remifentanil based analgesia and suggest the use of an 
opioid based analgesia in the early postoperative period. 
However opioid were necessary only in 1/3 of patients 
after sufentanil and fentanyl based analgesia while almost 
always necessary in case of remifentanil based analgesia. 
The necessity of anticipation of postoperative pain in case 
of remifentanil analgesia is well documented [5-7]. 
Nevertheless it is not always clear whether this anticipation 
should use opioid analgesics or other agents [8-10]. In 
addition, we could detect a delay in discharge criteria in 
the remifentanil group most probably related to higher 
pain scores and longer necessity of titration. On the other 
hand delay to extubation was shorter in the remifentanil 
group, this might have some advantages especially when 
neurologic assessment is mandatory [11]. Thyroid surgery 
is rated as being moderately painful [12, 13], therefore we 
hypothesized that anticipation of postoperative pain with a 
combination  of paracetamol and nefopam could 
adequately prevent postoperative pain and yield 
acceptable pain scores in all groups. However this was not 
the case as pain scores were significantly higher in the 
remifentanil groups. This difference might have several 
explanations, including the concept of hyperalgic activity 
after remifentanil based analgesia [14] but also the 
pharmacokinetic of fentanyl and sufentanil yielding a 
moderate degree of postoperative analgesia [15, 16 ]. Our 
study has some limitations including the fact the 
anesthetist in charge of the procedure was aware of the 
analgesic assignment, however since the outcome of the 
study was focused on immediate postoperative period we 
believe the results could not be affected. Postoperative pain Int. J. Med. Sci. 2006, 3 
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after thyroid surgery might have different explanations 
including the skin incision, pharyngolaryngeal morbidity 
after intubation and neck hyperextension [17, 18]. Multiple 
techniques and protocols have been suggested in order to 
decrease postoperative pain after this type of surgery, 
including local anesthetic using infiltration or cervical 
block and multimodal analgesia using (NSAID) [1, 2, 19]. 
We are aware that the latter drugs are also efficient in 
reducing morphine consumption in this type of surgery, 
however the addition of a third non opioid analgesic drug 
in addition to paracetamol and nefopam could have made 
the endpoint of the study more difficult to reach. Thyroid 
surgery is associated with high incidence of nausea and 
vomiting; however the incidence of these symptoms in our 
group of patients was comparable to other studies [20].  
In summary, when compared to fentanyl and 
sufentanil, the use of remifentanil was associated with a 
significant increase in immediate postoperative pain and 
the length of stay in the PACU. This study highlights the 
importance of anticipating postoperative pain by opioid 
when remifentanil is used even though when the surgery is 
described as yielding low to moderate level of post 
operative pain.  
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